PDCD1 and neoplasm: In murine models, the combination of is butyric acid with anti–PD-1 antibody markedly inhibited tumor growth, with tumor volumes reduced by approximately 80% and 60% compared with control and anti–PD-1 monotherapy groups, respectively.